Citation: E. Rabizadeh et al., MODULATION OF HEMATOPOIETIC GROWTH-FACTOR SECRETION FROM HUMAN MONONUCLEAR-CELLS BY A NOVEL BUTYRIC-ACID DERIVATIVE, European cytokine network, 9(3), 1998, pp. 64-64
Authors:
AVIRAM A
REPHAELI A
SHAKLAI M
NUDELMAN A
BENDROR I
MARON L
RABIZADEH E
Citation: A. Aviram et al., EFFECT OF THE CYTOSTATIC BUTYRIC-ACID PRO-DRUG, PIVALOYLOXYMETHYL BUTYRATE, ON THE TUMORIGENICITY OF CANCER-CELLS, Journal of cancer research and clinical oncology, 123(5), 1997, pp. 267-271
Authors:
BAIREY O
ZIMRA Y
SHAKLAI M
OKON E
RABIZADEH E
Citation: O. Bairey et al., EXPRESSION OF BCL-2, BAX AND BAK PROTEINS IN SHORT AND LONG-LIVED PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMAS, Blood, 90(10), 1997, pp. 3870-3870
Authors:
RABIZADEH E
SHAKLAI M
EISENBACH L
NUDELMAN A
REPHAELI A
Citation: E. Rabizadeh et al., ESTERASE INHIBITORS DIMINISH THE MODULATION OF GENE-EXPRESSION BY BUTYRIC-ACID DERIVATIVE, PIVALOYLOXYMETHYL BUTYRATE (AN-9), Israel journal of medical sciences, 32(12), 1996, pp. 1186-1191
Authors:
REPHAELI A
NORDENBERG J
AVIRAM A
RABIZADEH E
ZIMRA Y
NUDELMAN A
NOVOGRODSKY A
SHAKLAI M
Citation: A. Rephaeli et al., BUTYRATE-INDUCED DIFFERENTIATION IN LEUKEMIC MYELOID CELLS - IN-VITROAND IN-VIVO STUDIES, International journal of oncology, 4(6), 1994, pp. 1387-1391
Authors:
RABIZADEH E
SHAKLAI M
NUDELMAN A
REPHAELI A
Citation: E. Rabizadeh et al., ALTERATION OF GENE-EXPRESSION BY PIVALOYLOXYMETHYL BUTYRATE (AN-9), AND THE REDUCTION OF ITS EFFECTS BY ESTERASE INHIBITORS, Blood, 84(10), 1994, pp. 10000612-10000612
Authors:
RABIZADEH E
REPHAELI A
NUDELMAN A
TZEHOVAL E
SHAKLAI M
Citation: E. Rabizadeh et al., ENHANCEMENT OF LYMPHOKINES SECRETION BY A NOVEL BUTYRIC-ACID PRODRUG, Experimental hematology, 21(8), 1993, pp. 1185-1185
Authors:
RABIZADEH E
SHAKLAI M
NUDELMAN A
EISENBACH L
REPHAELI A
Citation: E. Rabizadeh et al., RAPID ALTERATION OF C-MYC AND C-JUN EXPRESSION IN LEUKEMIC-CELLS INDUCED TO DIFFERENTIATE BY A BUTYRIC-ACID PRODRUG, FEBS letters, 328(3), 1993, pp. 225-229